Emerging currencies slide as Iran war 'confusion’ jolts market

Emerging currencies slide as Iran war ‘confusion’ jolts market

Most emerging-market currencies weakened on Tuesday (May 26) as overnight clashes near the Strait of Hormuz offset signs of progress toward a US-Iran peace deal, even as developing-nation stocks rose on optimism around artificial intelligence. MSCI’s gauge traded little changed overall, though most developing world currencies fell. South Africa’s rand, seen as a benchmark for…

Read More
ONGC Q4 net profit declines QoQ, approves Dahej port JV; declares ₹1 dividend

ONGC Q4 net profit declines QoQ, approves Dahej port JV; declares ₹1 dividend

State-owned Oil and Natural Gas Corporation Ltd (ONGC) on Tuesday (May 26) reported a 20.6% quarter-on-quarter decline in net profit at ₹6,650 crore for the fourth quarter, compared with ₹8,372 crore in the previous quarter. Revenue increased 13.9% sequentially to ₹35,928 crore from ₹31,547 crore. EBITDA declined 17.1% quarter-on-quarter to ₹12,666 crore from ₹15,272 crore,…

Read More
Investment Strategy at 50: Lump Sum or SIP? 9 funds recommended by expert to plan smart and balance risk - Mutual Funds

Sensex Prediction Tomorrow, May 27: Index faces resistance near 76700; experts suggest selective buying for Wednesday – Markets

Sensex Prediction for Wednesday, May 27: Analysts believe the broader undertone for the market remains cautiously positive heading into Wednesday’s session, provided key support levels hold firm. Sensex Prediction for Wednesday, May 27: The Indian stock markets snapped their two-day winning streak on Tuesday, May 26, as escalating geopolitical tensions in the Middle East sparked…

Read More
IRCTC Q4 Results 2026: Dividend declared; profit falls 7% to Rs 332 crore YoY - Check quarterly earnings - Markets

IRCTC Q4 Results 2026: Dividend declared; profit falls 7% to Rs 332 crore YoY – Check quarterly earnings – Markets

IRCTC Q4 Results 2026: Indian Railway Catering and Tourism Corporation (IRCTC) on Tuesday has reported a mixed set of quarterly results for the fourth quarter ended March 31, 2026. The board also recommended a dividend for its shareholders. The company’s board recommended a final dividend of Rs 0.50 per equity share for the financial year…

Read More
ONGC Q4 Results FY26: Dividend declared; profit down 20% QoQ at Rs 6,650 crore - Check revenue and other quarterly earning details - Markets

ONGC Q4 Results FY26: Dividend declared; profit down 20% QoQ at Rs 6,650 crore – Check revenue and other quarterly earning details – Markets

The Oil and Natural Gas company has also declared a final dividend of Rs 1 for its shareholders. “The Board of Directors has recommended final dividend at the rate of ₹1/- per equity share of face value of ₹5/- each i.e. @20% for the Financial Year 2025-26 subject to the approval of shareholders at the…

Read More
Coal India OFS: Govt to sell up to 2% stake via offer for sale; floor price fixed at Rs 412 per share - Check key dates - Markets

Coal India OFS: Govt to sell up to 2% stake via offer for sale; floor price fixed at Rs 412 per share – Check key dates – Markets

Coal India OFS: The Government has announced an Offer for Sale (OFS) in Coal India Limited (CIL), comprising a base offer of 1 per cent equity with an additional 1 per cent Green Shoe Option in case of oversubscription. The floor price has been fixed at Rs 412 per share. “Government of India announces OFS…

Read More
AstraZeneca Dividend 2026: 1800% per share reward announced in Q4 results; revenue grows, profit declines - Check quarterly earnings - Markets

AstraZeneca Dividend 2026: 1800% per share reward announced in Q4 results; revenue grows, profit declines – Check quarterly earnings – Markets

AstraZeneca Dividend 2026: Pharmaceutical company, AstraZeneca on Tuesday posted its Q4 FY26 results. The company reported revenue of Rs 579 Cr in Q4 FY26, compared to Rs 480 Cr in Q4 FY25, registering a 20.4 per cent YoY increase. The board also recommended a dividend for its shareholders. AstraZeneca Pharma India has announced a generous…

Read More
Stocks to Watch for April 6: PNB, Tata Motors PV, RBL Bank, Rail Vikas Nigam and more

AstraZeneca Pharma India Q4 profit drops 23% despite strong revenue growth

AstraZeneca Pharma India reported a 23% year-on-year decline in net profit for the March quarter at ₹44.8 crore, compared with ₹58.2 crore in the corresponding period last year, as lower operating margins weighed on profitability despite robust revenue growth. Revenue from operations rose 20.4% year-on-year to ₹578.6 crore in Q4FY26 from ₹480.4 crore a year…

Read More